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Coxsackieviruses are significant human pathogens
causing myocarditis, meningitis, and encephalitis. We
previously demonstrated the ability of coxsackievirus
B3 (CVB3) to persist within the neonatal central nervous
system (CNS) and to target neural stem cells. Given that
CVB3 is a cytolytic virus and may therefore damage
target cells, we characterized the potential reduction in
neurogenesis within the developing brain and the sub-
sequent developmental defects that occurred after the
loss of these essential neural stem cells. Neonatal mice
were inoculated with a recombinant CVB3 expressing
eGFP (eGFP-CVB3), and alterations in neurogenesis and
brain development were evaluated over time. We ob-
served a reduction in proliferating cells in CNS neuro-
genic regions simultaneously with the presence of nes-
tin cells undergoing apoptosis. The size of the brain
appeared smaller by histology, and a permanent decrease
in brain wet weight was observed after eGFP-CVB3 infec-
tion. We also observed an inverse relationship between
the amount of virus material and brain wet weight up to
day 30 postinfection. In addition, signs of astrogliosis and
a compaction of the cortical layers were observed at 90
days postinfection. Intriguingly, partial brain wet weight
recovery was observed in mice treated with the antiviral
drug ribavirin during the persistent stage of infection.
Hence, long-term neurological sequelae might be ex-
pected after neonatal enteroviral infections, yet antiviral
treatment initiated long after the end of acute infection
might limit virus-mediated neuropathology. (Am J Pathol
2012, 180:1107–1120; DOI: 10.1016/j.ajpath.2011.11.016)Coxsackieviruses (CV) are a group of small, positive, single-
stranded RNA viruses that commonly cause human dis-
ease, including meningo-encephalitis1,2 and myocarditis.3
Neonatal CV infections are particularly damaging,4,5 and
infection of newborn infants may eventually lead to aseptic
meningitis3 and severe myocarditis.6 Of note, antibodies
against CV and other enteroviruses can be detected in
roughly 75% of the population.7 However, the long-term
consequences of an early CV infection in surviving individ-
uals are largely unknown. Correlations between prior infec-
tion and CNS disorders have been examined in children
with viral infections at infancy who were thought to have fully
recovered. One study found that 5 years after an initial viral
infection, these children had lower intellectual levels as
compared with those in control groups.8 These epidemio-
logical studies demonstrate the necessity of an animal
model in evaluating the lasting effects of an early CV infec-
tion on the developing CNS.
The B serotype of CV is characterized by spastic pa-
ralysis in suckling mice.9 Six coxsackievirus B serotypes
have been identified, and each is associated with acute
disease in humans. In particular, coxsackievirus B3
(CVB3) has been shown to be associated with infection of
the heart, central nervous system (CNS), and pancreas.
The determinants of CVB3 tropism in these organs re-
main poorly understood. Our laboratory has previously
shown that CVB3 preferentially infects nestin, proliferating
neural stem cells,10 and myeloid cells entering the CNS in
response to early infection.11 Also, we have recently dem-
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induce cytopathic effects within neurospheres grown in cul-
ture, which comprise neural stem cells and their progeny at
different stages of development12,13 Themain target sites of
early CVB3 infection in the neonatal brain included regions
of neurogenesis.10,14 Neural stem cells can be found in two
principal regions: the subventricular zone (SVZ), which lines
the lateral ventricles,15,16 and the dentate gyrus within the
hippocampus.17 Given that CVB3 efficiently infects both of
these regions, we hypothesized that CNS development and
might be greatly affected in the surviving host. Indeed, mice
infected with Theiler’s murine encephalomyelitis virus, amu-
rine picornavirus, experience disruption in their spatial
memory resulting frommajor damage to the pyramidal neu-
rons of the hippocampus.18
Although CVB3 is known to be cytolytic, persistence of
viral material may be observed within the heart19 and
CNS20 by mechanisms that remain unclear. Persistence
of CVB3 in target organs might involve virus attenuation
following the accumulation of genomic deletions within 5=
untranslated regions that may drastically slow virus rep-
lication.21–23 However, it remains uncertain how an atten-
uated CVB3 might evade the host innate and adaptive
immune response for extended periods. CVB3 has been
previously shown to attach to target cells through two
main receptors: decay-accelerating factor (DAF),24,25
and murine coxsackievirus and adenovirus receptor
(mCAR),26 which has been found to be highly expressed
in the developing brain.27 The high levels of mCAR ex-
pressed in neonatal organs might play a role in enhanced
susceptibility to CVB3 infection and disease. However,
high levels of cell proliferation (including neural stem
cells) expected during development may also increase
the number of potential target cells for CVB3 infection.28
Potential CVB3-induced damage to neural stem cells and
immature neurons may point to an underlying mechanism
of neurological disease. In this regard, CV and related
enteroviruses have been linked to neurological disorders
such as acute disseminated encephalomyelitis,29 schizo-
phrenia,30 amyotrophic lateral sclerosis,31,32 and, more
recently, demyelination33 or white matter damage.34
Therefore, we inspected the long-term effects of CVB3
infection on the central nervous system in our neonatal
murine model of infection. More specifically, we evalu-
ated the ability of CVB3 to induce apoptosis within neural
progenitor and stem cells (NPSCs). We also inspected
potential reductions in brain wet weight values within
mice surviving a prior CVB3 infection. Finally, we as-
sessed the degree of astrogliosis and cortical layer alter-
ations after CVB3 infection. Our results suggest that a
prior CVB3 infection during the neonatal period may lead
to lasting neurological disease in the surviving host.
Materials and Methods
Ethics Considerations
This study was performed in strict accordance with the
requirements pertaining to animal subjects protections
within the Public Health Service Policy and United StatesDepartment of Agriculture Animal Welfare Regulations.
All experimental procedures with mice were approved by
the San Diego State University Institutional Animal Care
and Use Committee (Animal Protocol Form #10-05-013F),
and all efforts were made to minimize suffering.
Mice and Viral Inoculations
BALB/c mice were obtained from Harlan Sprague Dawley
(Harlan Laboratories, San Diego, CA). Breeding mice
ranged between 6 and 8 weeks of age, and breeding
pairs were monitored daily to ensure that pups were
identified within 24 hours of birth. The procedure for intra-
cranial inoculation of pups has been described previ-
ously.14 Briefly, 1 or 3 days after the recorded date of birth,
pups were inoculated i.c. with 25 l Dulbecco’s modified
Eagle’s medium (DMEM; Cellgro, Manassas, VA) (mock-
infected control pups), or with either 106 or 107 pfu of eGFP-
CVB3. At various time points after infection, pups were
euthanized by placing them in a bell jar with isoflurane
followed by immediate decapitation. Alternatively, adult
mice were euthanized by isoflurane followed by cervical
dislocation. Brains were harvested, and brain wet weight
values were recorded immediately. One half of each brain
was fixed by immersion in 10% formaldehyde followed by
paraffin embedding; the other half of the brain was placed
into a tube and placed on dry ice. These samples were
eventually used to determine viral load by plaque assay and
real-time reverse transcription (RT)–PCR.
Isolation and Production of Recombinant
Coxsackievirus
The generation of a recombinant coxsackievirus express-
ing eGFP has been described previously.28 All virus
stocks were grown on HeLa RW cells maintained in
DMEM supplemented with 10% fetal bovine serum. Virus
titrations were performed as described previously.28
Virus Titration
Half of the brain saved for viral load determination was
weighed and homogenized with 1 mL of DMEM for 45
seconds using the Mini-BeadBeater (BioSpec Products,
Bartlesville, OK). Viral titers were measured using a stan-
dard CVB3 plaque assay, as published previously28
Briefly, HeLa RW cells were plated at 3.00 105 cells per
well in a six-well plate and were grown until 70% conflu-
ent (1 to 2 days). Tenfold serial dilutions were made, and
incubated with cells for 1 hour and then overlaid with 2X
complete DMEM mixed with 1.2% agar. After 40 to 48
hours of incubation at 37°C and 5% CO2, the cells were
fixed with 2 mL per well of methanol/acetic acid (3:1 v/v)
for 10 minutes. The fixative and plugs were then re-
moved, and plaques were stained with 1 mL per well of
0.25% Crystal Violet overnight. The plates were then
rinsed in water (three times), and plaques were counted.
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RT-PCR
Viral RNA was isolated from brain tissue using TRIzol
reagent (Gibco-BRL, Rockville, MD), as described by the
manufacturer. The quantitative real-time RT-PCR proce-
dure has been described previously.20 Briefly, reverse
transcription reaction mixtures included 1 g of total RNA
and were performed using SuperScript III Reverse Trans-
criptase (Invitrogen, Carlsbad, CA) following the proce-
dure described by the manufacturer. Separate RT reac-
tion mixtures containing 1 l of RNaseOUT (Invitrogen
Inc.) and reverse primer or forward primer were used to
quantify the number of positive- and negative-sense viral
genomes. PCR amplification was done using Platinum
quantitative PCR SuperMix-UDG ready-to-use cocktail
(Invitrogen), which contained all of the components
needed except the primers and probe, as described by
the manufacturer. Quantitative analysis of viral RNA was
performed using an iQ5 Real Time PCR Detection System
in 96-well optical reaction plates heated to 50°C for 2
minutes to digest dUTP-containing contaminants, fol-
lowed by 95°C for 2 minutes to deactivate uracil N-gly-
cosylase and to activate Platinum TaqDNA polymerase.
A total of 40 cycles of denaturation at 95°C for 15 sec-
onds and annealing and extension at 60°C for 30 sec-
onds were performed. All samples were evaluated in
triplicate amplification reactions. The procedure to nor-
malize the amount of RNA in each samples has been
described previously.20 CVB3 RNA generated via our
infectious viral clone (pH3 plasmid) was used to generate
the standard curve. The standard curve was based on
threshold cycle (CT) values, and CT values from unknown
samples were compared with the standard curve to de-
termine viral RNA copy numbers.
Histochemical and Immunofluorescence
Staining
Paraffin-embedded brain sections (3- to 4 m thick) were
stained by hematoxylin and eosin (H&E) or by Nissl stain.
For immunofluorescence microscopy, paraffin-embed-
ded sections were deparaffinized with three washes of
xylene, three washes with ethanol (100%, 95%, and
70%), and followed by washes in PBS and water. The
detection of apoptosis, neuronal class III -tubulin, nes-
tin, Ki-67, GFAP, and GFP required high-temperature an-
tigen unmasking in low-pH citrate buffer (Vector Labs,
Burlingame, CA). Immunofluorescence staining proce-
dures have been described previously.14 Apoptosis was
detected using the ApopTag Red In Situ Apoptosis De-
tection Kit (Chemicon/Millipore, Billerica, MA) as de-
scribed by the manufacturer. However, when the kit was
used in combination with an antibody against nestin (Co-
vance Research Products, Cumberland, VA), the protei-
nase K step was removed from the protocol. Neuronal
class III -tubulin was detected using a rabbit primary
antibody (Covance Research Products), diluted at 1:100.
Nestin was detected using a rabbit primary antibody
(nestin tail; Covance Research Products) diluted at1:100. Active caspase-3 was detected using a rabbit
primary antibody (Cell Signaling Technology) diluted at
1:100. Ki-67 was detected using a mouse primary anti-
body (Vector Labs) diluted at 1:100. The Mouse-On-
Mouse Kit (Vector Labs) was used for mouse primary
antibodies as instructed by the manufacturer. GFP was
detected using a rabbit primary antibody (Molecular
Probes, Carlsbad, CA) diluted at 1:100. The secondary
antibody used was a biotinylated goat anti-rabbit IgG
[heavy and light chains (HL)] (Vector Laboratories, Bur-
lingame, CA) diluted to 1:100 in 2% normal goat serum
and incubated on sections for 30 minutes. All sections
were then washed twice with PBS and incubated for 30
minutes with a streptavidin-green or streptavidin-red
complex (Molecular Probes/Invitrogen, Carlsbad, CA) di-
luted at 1:500 in 2% normal goat serum. Detection of
nuclei was done using Vectashield mounting medium
containing DAPI (Vector Laboratories). Sections were ob-
served by fluorescence microscopy (Zeiss Axio Observer
D1 with an attached Zeiss MRc camera; Zeiss,
Oberkochen, Germany) for the indicated cellular marker
(green or red), and DAPI (blue). Green, red, and blue
channel images were merged using AxioVision software
(Zeiss).
Brain Wet Weight Values
Wet weight measurements were taken at time of harvest by
placing the whole brain on a scale and recording the
weight. Wet weights values were analyzed using GraphPad
Prism 3.0 software, and the data were displayed graph-
ically. For the average wet weights graph, the infected
wet weights for each time point were compared with the
average wet weights of the mock-infected samples. Each
infected brain wet weight value was divided by the aver-
age mock weight for each time point, and the data were
analyzed using GraphPad Prism 3.0. Each time point
brain wet-weight value was compared with the respective
viral load quantities (viral titers or viral copies) and
graphed using Microsoft Excel scatter plots. Data were
analyzed by adding a trend line to decipher the relation-
ship between the two variables.
Ribavirin Treatment
Day 30 and day 90 postinfection (PI) mice received riba-
virin (100 mg/kg body weight) diluted in DMEM via sub-
cutaneous injections in the neck. Ribavirin treatment was
given every 3 days, starting at day 14 (for day 30 PI; total,
16 days) or day 60 (for Day 90 PI; total, 30 days). Mice
were euthanized, brains were harvested, and the brain
wet weight values were immediately determined.
Quantification of ApopTag Signal in
Subventricular Zone
SVZ sections of infected and mock-infected animals (three
animals per treatment and time point) were used for
ApopTag image collection using a Zeiss Axio Observer D1
inverted microscope. Quantification of apoptotic cells was
licate (
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3.0 software, analyzed, and displayed graphically. Each
apoptotic cell was then examined to determine co-localiza-
tion with nestin staining. The total amount of apoptotic cells
in sections from both infected andmock-infectedmice were
graphed using Microsoft Excel. Values represent the
amount of nestin or nestin apoptotic cells.
Results
Lethal Inoculation of CVB3 in Neonatal Mice
Causes Delay in Early CNS Development
Previously, we generated a neonatal murine model of
infection using a recombinant coxsackievirus B3 ex-
pressing eGFP (eGFP-CVB3) to study virus tropism and
pathogenesis.10,14 Lesions were observed in the olfac-
tory bulb, cortex, and hippocampal regions of the mouse
Figure 1. Lethal inoculum of eGFP-CVB3 during the neonatal period hinder
i.c.) or were mock infected. Brains were harvested and fixed in 10% neutral
H&E or immunostained for the cellular proliferation antigen (Ki-67, red) and
Two color channels were merged into a single image (original magnification
transverse section of the neonatal CNS for two representative mice. Normal
regions of neurogenesis in the CNS, a large number of Ki-67 cells were ob
with eGFP-CVB3 and harvested 5 days later, the overall size of the brain wa
lesions were seen in the hippocampus and cortex regions, in parallel with h
to no detectable viral protein levels and displayed similar numbers of prolifer
for day 5 fluorescent images revealed that the number of proliferating (Ki-67
as compared with mock-infected control mice. B: High levels of Ki-67 signa
signal was sharply reduced within infected mice. D: Quantification of Ki-6
infected mice (*P  0.0327). Quantification of Ki-67 cells was done in trip
software as described previously.10brain after acute CVB3 infection.14 The degree of pathol-ogy and the number of lesions were dependent on the
level of initial viral inoculum. Notably, these lesions were
observed for up to 9 months postinfection.20 To deter-
mine early CNS developmental changes after CVB3 in-
fection, 1-day-old mice were mock-infected or infected
i.c. with a high inoculum (2  106 pfu) of eGFP-CVB3.
Mice were sacrificed on days 1, 2, 3, and 5 PI, and the
brains were evaluated by H&E staining (Figure 1). The
exact time of pup birth was determined within a 24-hour
window. Subsequently, many pups infected with the high
viral inoculum did not survive longer than 4 days PI. Some
pups survived longer than 4 days PI (20% of mice
inoculated with 2 106 pfu i.c.); we propose that animals
surviving longer than 4 days PI may have been slightly
older pups inoculated at or after 16 hours postbirth.
In those animals lasting 5 days PI, clear histological
differences were observed in the infected brain, and the
overall size of the brain and olfactory bulbs appeared
evelopment. One-day-old pups were infected with eGFP-CVB3 (2  106 pfu
d formalin at the indicated time points PI. Paraffin sections were stained by
otein expression (GFP, green) and observed by fluorescence microscopy. A:
d composites of overlapping fields were assembled to illustrate a complete
velopment was observed in mock-infected pups. As would be expected for
n the SVZ near the lateral ventricles and in the cerebellum. In pups infected
antly smaller and the ventricles were severely distended. Furthermore, CNS
ls of viral protein expression. The cerebellum (only partly visible) had little
-67) cells compared with mock-infected control mice. Higher magnification
as substantially reduced in the SVZ (white arrow) near the lateral ventricles,
bserved in the SVZ of mock-infected mice. C: In contrast, the level of Ki-67
l in the SVZ showed substantially reduced levels of staining in the SVZ of
three mice per group and average of three fields per mouse) using ImageJs CNS d
buffere
viral pr
, 5) an
CNS de
served i
s signific
igh leve
ating (Ki
) cells w
l were o
7 signaconsiderably smaller than mock-infected control mice
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pression were observed in regions of the cortex and
hippocampus (Figure 1A), as determined previously.14
Taken together with our previously published results,10
these results suggested that CVB3 may affect normal
CNS development by targeting neural progenitor cells
and their downstream cell lineage products, immature
and mature neurons. We hypothesized that a reduction in
the number of proliferating NPSCs by apoptosis after
CVB3 infection may be responsible for the observed de-
lay in CNS development. Consequently, the number of
proliferating (Ki-67) cells in the neurogenic regions of
the developing CNS of infected mice appeared to be
reduced in number, as compared with those in mock-
infected control mice (Figure 1A) at a time when H&E
staining revealed severe developmental deficiencies in
the CNS.
Loss of Proliferating Cells in the SVZ After Lethal
CVB3 Infection
We quantified the relative level of Ki-67 proliferating
cells in the SVZ on day 5 PI in 1-day-old neonatal mice
infected with a high inoculum of eGFP-CVB3 (2  106
pfu) and mock-infected control mice, as determined by
immunofluorescence microscopy. As shown in Figure 1,
B and C, a clear reduction in the number of proliferating
cells in the SVZ was observed within infected mice, sug-
gesting alterations in normal levels of neurogenesis after
CVB3 infection. The reduction of proliferating cells at day
4 PI in infected animals (three mice per treatment) was
quantified by analysis with ImageJ software (Figure 1D)
and shown to be statistically significant (P  0.0327), as
compared with values in mock-infected mice.
Lethal CVB3 Infection Induces Apoptosis in
Neurogenic Regions of Developing CNS
Our previous studies identified CVB3-infected neurons
undergoing caspase-3–mediated apoptosis in the neo-
natal hippocampus and entorhinal cortex at day 3 and
day 5 PI.14 The observed reduction of proliferating (Ki-
67) cells within neurogenic areas of the CNS, in combi-
nation with delayed CNS development, suggested to us
that neural stem cells also may be depleted in the SVZ
after CVB3 infection. Therefore, we inspected the level of
apoptosis within neurogenic regions of the CNS at early
(day 1 and day 2 PI) and later (day 5 PI) time points after
infection with eGFP-CVB3 to determine whether the delay
in CNS development may be due to the programed cell
death of infected NPSCs within the SVZ.
Intriguingly, apoptotic cells (ApopTag staining, red)
were observed within the rostral migratory stream (RMS,
outlined by neuronal class III -tubulin expression shown
in green) as soon as day 1 PI (Figure 2A). These apop-
totic cells were identified as neuroblasts by their expres-
sion of neuronal class III -tubulin. In contrast, mock-
infected neonatal mice showed little to no apoptotic
activity within the RMS (Figure 2B). Also, numerous cells
undergoing apoptosis were observed within the SVZ 2days PI (Figure 2C). Regions of apoptosis overlapped
directly with areas of infection (green), as determined by
viral protein expression. Higher magnification revealed
apoptotic cells adjacent to infected cells near the
ependymal cell layer (Figure 2D). By day 5 PI, high levels
of viral protein expression and apoptosis were observed
in the hippocampus and cortex regions of the neonatal
CNS (Figure 2E), similar to what was described previ-
ously after infection with eGFP-CVB3.14 Higher magnifica-
tion of the hippocampus revealed ApopTag staining within
the dentate gyrus and CA1-3 regions of the hippocampus
(Figure 2F). Although strong viral protein expression levels
were evident in the dentate gyrus, reduced levels were
detectable in other regions of the hippocampus, perhaps
reflecting the reduced numbers of viable cells in Ammon’s
horn at later time points. In contrast, little or no apoptosis
was observed in the hippocampus or SVZ of mock-infected
control animals (Figure 2G).
Nestin and Nestin Cells in Neurogenic
Regions Undergo Apoptosis After Lethal CVB3
Infection
Although cells undergoing apoptosis were observed
within neurogenic regions, we determined whether these
apoptotic bodies represented NPSCs or other glial cells.
Therefore, we quantified the total number of apoptotic
nestin and nestin cells in the SVZ after CVB3 infection.
By fluorescence microscopy, many nestin cells (green)
were observed in the SVZ undergoing apoptosis (red) at
24, 36, and 48 hours PI (Figure 2, H, I, and J, respec-
tively). The total number of apoptotic nestin and nestin
cells was quantified in CVB3-infected and mock-infected
mice (Figure 2K). Greater numbers of apoptotic cells
were observed in the SVZ of infected mice at all three
time points, as compared with mock-infected control an-
imals (P  0.0042). Also, a greater number of nestin
cells undergoing apoptosis was observed, as compared
with nestin cells within infected mice at all three time
points after infection, although these values were not
statistically significant. We hypothesize that nestin cells
undergoing apoptosis may represent downstream neural
precursor cells or unidentified cells present in the SVZ.
Establishment of Viral Persistence in the
Neonatal Mouse CNS After Inoculation with
Nonlethal Dose of CVB3
Our results clearly demonstrate that neonatal mice inoc-
ulated with a lethal dose of eGFP-CVB3 showed reduced
levels of neurogenesis and profound CNS developmental
delays at early time points (up to day 5 PI). However, we
speculated whether CVB3 infection may lead to lasting
consequences in the CNS within surviving mice. There-
fore, we inspected the later stages of infection, ongoing
neuropathology, and long-term consequences on CNS
development in neonatal mice inoculated with a nonlethal
dose of virus determined by a survival curve in a previous
study.20 Three-day-old mice inoculated with eGFP-CVB3
(2 107 pfu i.c.) survived acute infection and established
ls was s
point.
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titers were observed up to day 5 PI (Figure 3A). By day 10
PI and beyond, infectious virus could no longer be de-
tected by conventional plaque assay. However, viral RNA
was observed by real-time RT-PCR up to day 90 PI,
although RNA abundance decreased substantially over
time (Figure 3B).
High Levels of Apoptosis in SVZ of Mice
Surviving CVB3 Infection
We quantified the level of apoptosis in the SVZ of mice
inoculated with a sublethal dose of eGFP-CVB3. Infected
and mock-infected mice were stained for apoptotic cells
in the SVZ and observed by fluorescence microscopy
over time (Figure 4). For each mouse (three mice per
group), three representative brain sections were quanti-
fied by fluorescence microscopy to determine the
amount of apoptotic cells within the SVZ. As shown for
mice inoculated with a lethal dose of eGFP-CVB3, mice
Figure 2. High levels of apoptosis in neurogenic regions observed in both
3 days old were infected with eGFP-CVB3 (2  106 – 1  107 pfu i.c.) or m
apoptotic activity by ApopTag staining. A: An increase in the level of apopto
mice. These apoptotic cells were identified as neuroblasts which migrate thro
were identified in mock-infected control mice. C: Clear apoptotic activity (red
the boundary between the ependymal cell layer and the lateral ventricle. D
(GFP) cells. E: By day 5 PI, high levels of apoptosis were observed near th
supported high levels of viral protein expression. F: Higher magnification of
of Ammon’s horn. G: In contrast, mock-infected control pups showed little or
neural stem and progenitor cells undergoing apoptosis within the SVZ. Immu
(red) at 24 (H), 36 (I), and 48 hours PI (J), (white arrows), respectively. K
progenitor cells by nestin staining. Also, the total number of apoptotic cel
(*P  0.0042). For quantification, three mice were used per group and timesurviving infection exhibited relatively high levels ofapoptosis within the SVZ for up to day 10 PI, as com-
pared with mock-infected control mice (Figure 4A). By
day 30 PI and beyond, few apoptotic cells could be seen
in the SVZ of both infected and mock-infected mice.
These results suggest that acute CVB3 infection rapidly
depleted target cells within the SVZ. Eventually, the level
of virus-mediated apoptosis waned in parallel with a drop
in viral titers and/or a reduction in target cell populations
as the animals aged.
Also, infected cells undergoing apoptosis were identi-
fied in the hippocampus and in neurogenic regions after
infection (Figure 4, B and D). Immunofluorescence mi-
croscopy showed the induction of active caspase-3 (red)
in the RMS, the SVZ (data not shown), and within infected
regions of the CA2 region of the hippocampus. Higher
magnification demonstrated colocalization of infected
cells with those expressing active-caspase 3 in both the
RMS and the hippocampus (Figure 4, C and E, respec-
tively) suggesting eGFP-CVB3 could directly induce
apoptosis in neurogenic regions. Single channel images
and nestin- cells following a lethal inoculation with eGFP-CVB3. Pups 1 or
cted. Brain sections from pups harvested up to day 5 PI were examined for
(red) was seen in the RMS of infected pups as compared with mock-infected
RMS by staining for neuronal -tubulin (green). B: Little to no apoptotic cells
lso observed in the SVZ as early as day 2 PI. The white dotted line represents
r magnification revealed apoptotic cells located adjacent or within infected
l ventricles, the hippocampus, and regions of the cortex. These regions also
ocampus demonstrated apoptosis in the dentate gyrus and in the CA3 region
ptotic activity in the CNS. H–J: Using nestin (green) as a marker we identified
escence microscopy identified nestin cells in the SVZ undergoing apoptosis
than 50% of cells undergoing apoptosis were identified as neural stem and
ignificantly higher in infected mice, as compared with mock-infected micenestin
ock infe
tic cells
ugh the
) was a
: Highe
e latera
the hipp
no apo
nofluor
: Moreconfirmed the overlap of active caspase-3 and viral pro-
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recent findings showing eGFP-CVB3-induced cytopath-
icity in NPSCs grown in culture.12 Although high levels of
active caspase-3 were also observed in nearby cells
having no detectable levels of viral protein, these cells
might represent infected cells that no longer express
detectable levels of viral protein because of the com-
promised status of the cell, or cleavage of viral proteins
by proteases induced during apoptosis. Alternatively,
eGFP-CVB3 may indirectly induce apoptosis of nearby
cells, as shown for Theiler’s murine encephalomyelitis
virus.35
Reduced Brain Wet Weights in Mice Surviving
CVB3 Infection
We hypothesized that any reduction of NPSCs in mice
surviving infection might alter normal brain development
and size. Therefore, we quantified brain wet weights in
Figure 3. Viral titers over time in 3-day-old mice after a nonlethal inocula-
tion with eGFP-CVB3. Pups 3 days old were infected with an amount of viral
inoculum whereby mice survived infection (eGFP-CVB3 at 1  107 pfu i.c.).
Brains were harvested and virus titers in brain homogenates were deter-
mined by plaque assay. A: Early time points (days 1, 2, and 5) showed high
viral titers for multiple animals. At later time points (days 10, 30, and 90), no
detectable infectious virus was observed. B: In contrast, viral RNA was
detected by real-time RT-PCR up to day 90 PI (three mice per time point)
demonstrating the presence of viral genomic material for extended periods.both infected and mock-infected control mice duringacute infection and in persistently infected mice. As seen
in Figure 5, a significant decrease in brain wet weight
values of infected mice was observed at days 1, 5, 10,
30, and 90 PI, as compared with mock-infected control
mice. Also, an inverse relationship was observed be-
tween brain wet weight values and viral titers (as mea-
sured by plaque assay) within infected mice - the higher
the viral load the lower the brain wet weight. However, the
trend was no longer evident at day 90 PI, possibly be-
cause of the relatively low viral copy levels detected at
this later time point.
Administration of Antiviral Drugs During
Persistent Stage of CVB3 Infection Leads to
Partial Brain Wet Weight Recovery
Previously, we detected the presence of attenuated CVB3
within the CNS of persistently infected mice that continued
to replicate on passage in HeLa cells.36 We hypothesized
that an antiviral drug such as ribavirin given during the
persistent phase of infection in vivo might inhibit the low
levels of ongoing viral replication in the CNS. We pre-
dicted that any reduction in viral load during persistent
infection might lead to brain wet weight recovery. Riba-
virin targets replicating RNA viruses by increasing the
amount of nucleotide mutations to an unsustainable high
rate whereby the virus is unable to retain genomic stabil-
ity and in driven into “lethal mutagenesis.”37
Published reports have described the ability of ribavi-
rin to inhibit coxsackievirus replication in culture or during
early infection in vivo.38 Also, ribavirin has been previ-
ously shown to enter through the blood–brain barrier at
levels sufficient to inhibit some neurotropic viral infec-
tions, including enterovirus infections. Therefore, we in-
jected ribavirin i.p. into persistently infected mice in an
effort to observe brain wet weight recovery. For day 30 PI
persistently infected mice, ribavirin was injected at day
14 and every third day thereafter until harvest (total of 16
days treatment). For day 90 PI persistently infected mice,
ribavirin was injected at day 60 and every third day there-
after until harvest (total of 30 days treatment). A 16-day
treatment of ribavirin failed to show brain wet weight
recovery in day 30 PI mice (Figure 5). In contrast, day 90
PI mice treated with ribavirin for 30 days showed a sta-
tistically significant brain wet weight recovery (Figure 5;
P  0.03). These results suggest that ribavirin treatment
during the persistent phase of CVB3 infection may be
beneficial in limiting CNS pathology. Ribavirin is a nucle-
oside analog, and would be expected to only be effec-
tive during active viral replication. Its apparent efficacy
at day 90 PI, but not at day 30 PI, suggests that CVB
replication may fluctuate over the course of a persis-
tent infection. A comparison of brain wet weight nor-
malized to average mock-infected brain wet weight for
all animals analyzed at each time point illustrated the
highly significant reduction in brain size of mice in-
fected with eGFP-CVB3 across all time points analyzed
(Figure 6; P  0.0001).
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Mice Surviving CVB3 Infection
The brains of day 30 and day 90 PI mice were inspected
for the presence of lasting neuropathology that may be
attributed to a reduction in neurogenesis after eGFP-
CVB3 infection. We previously observed CNS lesions and
microgliosis in persistently infected mice. By immunoflu-
orescence microscopy, high levels of GFAP staining in
the hippocampus of persistently infected mice as com-pared with mock-infected control mice indicated the
presence of astrogliosis in persistently infected mice at
day 30 (Figure 7, A and B) and day 90 PI (Figure 7, D and
E). Astrogliosis represents an increase in the proliferation
of astrocytes after the loss of nearby neurons. The quan-
tification of GFAP signal per section clearly demonstrated
an increase in astrogliosis after eGFP-CVB3 infection in
surviving mice (Figure 7, C and F). We hypothesize that the
observed astrogliosis may represent either residual viral
Figure 4. Surviving mice infected with eGFP-
CVB3 showed higher levels of apoptosis in the
SVZ up to 10 days PI, as compared with mock-
infected mice. Three day-old pups were in-
fected with eGFP-CVB3 (1  107 pfu i.c.) or
were mock infected. A: Levels of apoptosis
were quantified in the SVZ for both infected
and mock-infected mice by ApopTag staining.
Higher levels of apoptosis were observed spe-
cifically within infected mice during acute
time points (days 1, 2, and 5 PI). By day 90 PI,
levels of ApopTag staining were below detec-
tion limits for both infected and mock-infected
mice. B and D: Active caspase-3 (red) was
detected by immunofluorescence microscopy
within the hippocampus and in neurogenic
regions at 36 hours PI. High levels of active
caspase-3 were observed near sites of infec-
tion in the RMS (B) and in the CA2 region of
the hippocampus (D; green). C and E: Higher
magnification of (B) and (D), respectively,
showed colocalization of active caspase-3
with cells expressing high levels of viral pro-
tein (white arrows). Single-channel images
for active caspase-3 and viral protein demon-
strated the overlapping red and green signal.
Nuclei/DNA were stained with DAPI (blue).replication during the persistent phase of infection, or alter-
bavirin-t
irin-treat
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neurons which remained at later time points. CNS lesions
within the CA3 region of Ammon’s horn and dentate gyrus of
the hippocampus were also observed by Nissl staining at
day 90 PI (Figure 7, G and H). In addition, we also observed
a reduction in the size of the brain cortex after eGFP-CVB3
infection at day 90 PI by Nissl staining (Figure 7, I and J).
Higher magnification of Figure 7, I and J, revealed a com-
Figure 5. Surviving mice infected with eGFP-CVB3 exhibited reduced brain w
3 days old were infected with eGFP-CVB3 (1  107 pfu i.c.) or mock infecte
or mock-infected mice were determined. Infected mice showed a statistically
0.7162), day 5 PI (‡P 0.0339), day 10 PI (§P 0.037), day 30 PI (¶P 0.05),
the brain wet weights of infected mice and viral RNA load up to day 30 PI (
viral RNA load. Student’s t-test was used to compare brain wet weights for in
infected mice at late time points to determine whether viral replication during
regimens were used for day 30 (administered 2 weeks before harvest; treatment
Although no significant change in brain wet weights was observed for day 30 ri
revealed a significant increase (*P  0.03) in brain wet weight for day 90 ribav
Figure 6. Surviving mice infected with eGFP-CVB3 from all time points
showed reduced brain wet weights, as compared with averaged brain
weights of mock-infected mice. Pups 3 days old were infected with eGFP-
CVB3 (as described in Figure 5) or mock-infected. Brain wet weights from
infected and mock-infected mice were normalized to average mock-infected
brain wet weights for each time point. The normalized brain wet weight
results for animals from all time points (days 1, 2, 5, 10, 30, and 90 PI) are
graphically displayed. A highly significant difference was observed between
infected and mock-infected brain wet weights when mice from all time points
were compared (P  0.0001; Student’s t-test).paction of the cortical layers and reduced germinal cells in
the SVZ layer of infected mice, as compared with mock-
infected control mice (Figure 7, K and L).
Our model of lasting CVB3-mediated neuropathology
is described in Figure 8. We propose that type B, C, and
A stem cells are the main early targets of this highly
cytolytic virus, and may undergo early apoptosis after
infection. CVB3-mediated apoptosis of infected nestin
NPSCs and their differentiated counterparts may lead to
a rapid decline in neurogenesis and may eventually
cause developmental defects reflected in our study by
reduced brain wet weight values and alterations in cortex
size. Finally, ribavirin may act on persistently infected
stem cells and/or neurons, and a reduction in viral repli-
cation may lead to partial brain wet weight recovery.
Discussion
Little is known regarding the long-term consequences
of a neurotropic CVB3 infection on the CNS of the
developing host. We previously demonstrated that
CVB3 infects NPSCs in the SVZ and RMS of the
CNS.10,14 The SVZ is located near the lateral ventricles
of the brain and comprises NPSCs that migrate through
hts at early and late time points, as compared with mock-infected mice. Pups
arvested up to day 90 PI. At time of harvest, brain wet weights for infected
ant reduction in brain wet weights on day 1 PI (*P  0.0468), day 2 PI (†P 
90 PI (P 0.03). Also, an inverse relationship trend was observed between
mined by real time RT-PCR): the lower the brain wet weight, the higher the
nd mock-infected animals. The antiviral drug ribavirin was injected i.p. into
nce contributed to the observed reduced brain wet weights. Different treatment
days) and day 90 (administered 30 days before harvest; treatment every 3 days).
reated infected mice, analysis of variance analysis with Newman–Keuls method
ed infected mice, as compared with untreated infected animals.et weig
d and h
signific
and day
as deter
fected a
persiste
every 3the RMS and radially differentiate into functional olfactory
overal
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AJP March 2012, Vol. 180, No. 3neurons.39–41 Also, CVB3 preferentially replicated within
proliferating cells,28 which might explain its preference
for targeting NPSCs.10,42 Susceptibility to CVB3 is highly
dependent on the age of the host, perhaps because of
the greater number of proliferating cells in the developing
host, which might serve as highly susceptible target
Figure 7. Astrogliosis and neurological abnormalities in mice surviving C
or mock-infected. Brains from days 30 and 90 PI were inspected for signs
quantified by GFAP immunofluorescence in both mock-infected (A) and
within infected mice at 30 days PI, as compared with mock-infected contr
by ImageJ analysis and the results were shown to be statistically significa
of GFAP remained within the hippocampus of infected mice (E) as long
as quantified by ImageJ analysis (P  0.0407). Compared with mock-in
appeared smaller 90 days PI by Nissl staining. Also, some infected mice
(green arrows). Compared with mock-infected mice (I), the cortex of in
with mock-infected mice (K), closer inspection of the cortex revealed the
layer of infected mice (L).cells.14 Despite infection, NPSCs continued to migrate anddifferentiate into neurons,14 although many infected neu-
rons eventually underwent caspase-3–induced apoptosis.
We hypothesized that potential reduction of neurogenesis
because of stem cell death after CVB3 infection might lead
to developmental defects and CNS dysfunction.18
Here, we show that a lethal inoculation of eGFP-CVB3
ection. Pups 3 days old were infected with eGFP-CVB3 (1  107 pfu i.c.)
g CNS defects and neuropathology., Astrogliosis in the hippocampus was
d (B) mice. Relatively higher levels of GFAP expression were observed
C: Higher GFAP levels seen for infected mice 30 days PI were quantified
0.0503). Compared with mock-infected mice (D), relatively higher levels
ys PI. F: GFAP levels in the hippocampus remained higher at 90 day PI,
ice (G), the overall size of the hippocampus within infected mice (H)
ed lesions in the CA3 region of Ammon’s horn and in the dentate gyrus
ice (J) also appeared to be smaller in width by Nissl staining. Compared
l compaction of the cortical layers and reduced germinal cells in the SVZVB3 inf
of lastin
infecte
ol mice.
nt (P 
as 90 da
fected m
exhibit
fected malso induced apoptosis within nestin NPSCs in the SVZ
eurons
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neonatal CNS. Expression of eGFP by our recombinant
CVB3 has been very helpful in characterizing neural pro-
genitor cell tropism of the virus and tracking virus dis-
semination using our neonatal murine model of infection.
Previous studies have used eGFP expressed under the
promoter of neural stem and progenitor cell-specific
genes such as nestin, GFAP, or Sox2 to successfully
label and track neural progenitor cells with no apparent
impact on neurogenesis or CNS development.43–45
Neuroblasts in the RMS were directly observed under-
going apoptosis after infection, which might account for
the reduction in the size of olfactory bulbs, as compared
with mock-infected mice. More than 50% of apoptotic
cells at 24, 36, and 48 hours PI were found to express
nestin, a marker for NPSCs. The remaining cells undergo-
ing apoptosis have not yet been identified. However, be-
cause of their location within the SVZ in the neonatal CNS,
these cells might represent downstream progenitor cells
lacking detectable levels of nestin expression. Consider-
able CNS damage was observed in lethally inoculated
mice; as early as day 5 postinfection (PI) a reduction in
the size of the brain was seen simultaneously with high
levels of virus protein expression in the SVZ, hippocam-
pus, and cortex.
One-day-old mice infected with CVB3 exhibited high
lethality; hence, these studies did not allow long-term
analysis of CNS defects to be conducted. Therefore, we
used 3-day-old mice to extend the lifespan of infected
mice and determine long term consequences of infection
on the developing CNS. By ApopTag staining, we deter-
mined that a sublethal inoculum of CVB3 also induced
high levels of apoptosis in the SVZ, as compared with
mock-infected control mice. We hypothesized that CVB3
directly harmed NPSCs by inducing apoptosis. However,
technical limitations associated with ApopTag staining
limited our ability to directly identify infected cells un-
dergoing apoptosis. Therefore we used active
Figure 8. Model for coxsackievirus-induced depletion of progenitor cells a
populations of neural stem and progenitor cells (NPSCs; type B, C, and A
migratory neuroblasts (type A cells). NPSCs migrate through the rostral mig
olfactory bulb or cortex. In an infected mouse (center column), CVB3 inf
population of cells. Other infected NPSCs survive initial infection and migra
in the dissemination of virus. Many infected neurons eventually undergo ap
reduction in neurons and neurodevelopmental defects. In an infected mou
persistence may be reduced. After ribavirin treatment, progenitor cells and n
partial brain wet-weight recovery in the mouse.caspase-3 staining, an early marker of programed celldeath, to directly show apoptosis of infected cells
within neurogenic regions of the CNS. These results
parallel our recent publication demonstrating cyto-
pathic effects and cell death by trypan staining in
NPSCs infected in culture.12
Nonetheless, we cannot rule out the possibility that
CVB3 may indirectly cause apoptosis in some cells by
the induction of the innate immune response and/or infil-
trating immune cells.35 For example, we have recently
described the influx of Iba1 macrophages/microglia
that engulfed infected myeloid cells undergoing apopto-
sis within the choroid plexus at early time points after
infection.11 These cells were also found in the SVZ fol-
lowing infection at a time point when nestin and nestin
cells were observed undergoing apoptosis. Therefore
Iba1 macrophages/microglia, or similar immune cells
responding to infection, may play a role in NPSC apop-
tosis or the subsequent removal of dying cells by the
process of phagocytosis.
As might be expected, a reduction in brain wet weight
values were observed during acute infection (days 1, 2,
and 5 PI) and during persistent infection (day 10, 30, and
90 PI) at a time when viral RNA could be detected in the
absence of infectious virus. These results suggested
CNS developmental defects after infection, most likely
because of targeting of NPSCs. The amount of viral ma-
terial (infectious virus or viral RNA) was analyzed with
respect to brain wet weight values for each mouse to
shed light on the association between the amount of virus
and brain size. An inverse relationship between virus and
brain wet weight values was clearly observed and ap-
peared to grow stronger over time. However by day 90 PI,
the inverse relationship was no longer seen, perhaps
because of the relatively low viral load observed at this
time point as determined by real-time RT-PCR.
Ribavirin has been successfully used to combat en-
terovirus infections. For example in one study examining
enterovirus 71 infection in mice, the authors observed a
ons in the CNS. The SVZ of noninfected mice (left column) contains three
tor cells). Type B cells give rise to type C cells, which eventually produce
ream (RMS) or radial glia (RG) and differentiate into mature neurons in the
ral NPSCs. Some infected NPSCs undergo apoptosis depleting the resident
ifferentiate into neurons within the CNS. The infected migratory cells assist
. Apoptosis of NPSCs and neurons following CVB3 infection may lead to a
d with ribavirin (right column), ongoing sporadic viral replication during
may be protected from ongoing infection and apoptosis, thereby leading tond neur
progeni
ratory st
ects neu
te and d
optosis
se treatereduction in mortality of mice after the administration of
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Ribavirin can successfully cross the blood–brain bar-
rier,46 suggesting that this antiviral drug might be effec-
tive in limiting CVB3 infection within the CNS. Antiviral
drugs, such as ribavirin typically target the replication
cycle of viruses. Ribavirin is thought to induce “lethal
mutagenesis” in viral populations47 by increasing the
viral mutation rate over a threshold of tolerable muta-
tions. Therefore, we assessed the ability of ribavirin to
improve brain wet-weight values in infected mice. How-
ever, rather than treat infected mice during acute in-
fection (a point in time when an antiviral drug would
most likely reduce viral titers), we delayed ribavirin
treatment until the persistent stage of infection. We
hypothesize that any improvement in brain wet weight
values in mice treated at later time points (day 14 or
day 60) might indicate ongoing virus replication during
the persistent stage of infection. Infected mice treated
with ribavirin at day 60 PI (every 3 days) and harvested
at day 90 PI (antiviral treatment for a total of 30 days)
showed a significant recovery of brain wet weight val-
ues, as compared with untreated, infected mice. Nev-
ertheless, the brain wet weight values of ribavirin-
treated mice remained below the values for mock-
infected mice. These results suggest that antiviral
drugs given during the persistent stage of infection
may be beneficial in improving brain recovery. In ad-
dition, these results indirectly suggest that CVB3 may
continue to replicate in the CNS at late time points
(from day 60 to 90 PI), despite the absence of infec-
tious virus as measured by plaque assay. In contrast,
brain wet weight values of infected mice treated with
ribavirin at day 14 PI (every 3 days) and harvested at
day 30 PI (antiviral treatment for a total of 16 days)
failed to improve. We suggest that the 16 day ribavirin
treatment was insufficient to contribute to brain wet
weight recovery in these mice.
Previous studies have suggested causal links be-
tween virus infection and behavioral disorders in hu-
mans.8 Some reports have suggested an association of
coxsackievirus infection with neurological disorders,
such as schizophrenia.30 Based on our existing data,
we suggest that acute CVB3 infection may cause a
significant amount of damage to neurogenic regions of
the CNS, and the brain may be unable to fully recover.
Other viruses have also been shown to target neural
stem cells and alter neurogenesis including human
cytomegalovirus,48,49 Japanese encephalitis virus50–54
and human immunodeficiency virus.55 Our results sug-
gest that CNS injury and pathology after CVB3 infection
may involve a direct effect of virus infection on NPSCs.
Nonetheless, the immune response against viral infec-
tion may also play a critical role as the mechanism of
CVB3 neuropathology in our neonatal murine model.
For example, acute disseminated encephalomyelitis
following an enteroviral infection29 might be consid-
ered a postinfectious condition with an underlying im-
munopathological response. Treatment with steroids
and other anti-inflammatory and immunosuppressive
therapies have shown a beneficial effect in patients
with acute disseminated encephalomyelitis.56Also, we have previously described viral persistence
and chronic immunopathology in mice surviving CVB3
infection during the neonatal period. Most likely, our ob-
served developmental defects and reduced brain wet-
weight values after CVB3 infection might reflect a com-
bination of direct infection of neural stem cells with
resultant cytopathicity, along with an ongoing and dele-
terious immunopathological response against viral infec-
tion. Our recently published manuscript12 indicates that
acute CVB3 infection may alter neural progenitor cell
differentiation by increasing the percentage of cells ex-
pressing neuronal class III -tubulin after their differenti-
ation in the presence of fetal bovine seum. However, more
studies are necessary to determine which lineage may
show the greatest impact after CVB3 infection in the host.
For example, a total reduction across all cell lineages may
occur after infection despite a percentage increase in
neuronal, as compared with glial cell lineages.
A more comprehensive assessment of the geographic
distribution of viral infection in the CNS over multiple time
points has been evaluated previously.10,14,20 Neverthe-
less, our previous studies and the current study directly
demonstrate the susceptibility of neural stem and pro-
genitor cells in the subventricular zone to CVB3 infection.
Also, infection of the dentate gyrus suggests that neural
stem cells in the hippocampus may be susceptible to
infection. In contrast, the cerebellum and cerebellar pro-
genitor cells may be less susceptible to infection. Hence,
the susceptibility of neural progenitor cells may not be
completely uniform across the brain. We have recently
isolated neural progenitor cells from all three neurogenic
regions of the CNS to determine whether CVB3 prefers a
subpopulation of neural progenitor cells. These studies
may help to determine whether particular regions of the
CNS may be impacted after infection. Even so, the results
described in the manuscript revealed a compaction of
the cortical layers and reduced germinal cells in the SVZ
layer of infected mice, as compared with mock-infected
control mice (Figure 7), suggesting depletion of neural
progenitor cells in the subventricular zone.
The presence of persistent viral RNA that continue to
replicate at a low or undetectable level might contribute
to lasting CNS damage after CVB3 infection. Of note, we
anticipate substantial possible learning disabilities after
neonatal enterovirus infection based on these studies.
One of the main targets of CVB3 appears to be the
hippocampus, a region responsible for learning and
memory. Hence, any hippocampal damage occurring
after infection may impact learning and memory tasks in
surviving individuals.18 Our ongoing studies inspecting
murine behavior suggest memory alterations in C57 BL/6
mice surviving an early CVB3 infection (manuscript in
preparation). The observed damage in the CNS of sur-
viving mice after CVB3 infection necessitates further in-
vestigations to clarify possible long-term repercussions in
those individuals diagnosed with neurotropic enterovirus
infections during infancy, and a need for designing anti-
viral drugs and vaccines for controlling enterovirus infec-
tions in the human host.
Enteroviruses and Stem Cell Depletion 1119
AJP March 2012, Vol. 180, No. 3References
1. Berger JR, Chumley W, Pittman T, Given C, Nuovo G: Persistent
Coxsackie B encephalitis: report of a case and review of the literature.
J Neurovirol 2006, 12:511–516
2. Kamei S, Hersch SM, Kurata T, Takei Y: Coxsackie B antigen in the
central nervous system of a patient with fatal acute encephalitis:
immunohistochemical studies of formalin-fixed paraffin-embedded
tissue. Acta Neuropathol (Berl) 1990, 80:216–221
3. Whitton JL, Cornell CT, Feuer R: Host and virus determinants of
picornavirus pathogenesis and tropism. Nat Rev Microbiol 2005,
3:765–776
4. Romero JR: Pediatric group B coxsackievirus infections. Curr Top
Microbiol Immunol 2008, 323:223–239
5. Wikswo ME, Khetsuriani N, Fowlkes AL, Zheng X, Penaranda S,
Verma N, Shulman ST, Sircar K, Robinson CC, Schmidt T, Schnurr D,
Oberste MS: Increased activity of Coxsackievirus B1 strains associ-
ated with severe disease among young infants in the United States,
2007–2008. Clin Infect Dis 2009, 49:e44–e51
6. Verma NA, Zheng XT, Harris MU, Cadichon SB, Melin-Aldana H,
Khetsuriani N, Oberste MS, Shulman ST: Outbreak of life-threatening
coxsackievirus B1 myocarditis in neonates. Clin Infect Dis 2009,
49:759–763
7. Sawyer MH: Enterovirus infections: diagnosis and treatment. Semin
Pediatr Infect Dis 2002, 13:40–47
8. Chamberlain RN, Christie PN, Holt KS, Huntley RM, Pollard R, Roche
MC: A study of school children who had identified virus infections of
the central nervous system during infancy. Child Care Health Dev
1983, 9:29–47
9. Hyypia T, Kallajoki M, Maaronen M, Stanway G, Kandolf R, Auvinen P,
Kalimo H: Pathogenetic differences between coxsackie A and B virus
infections in newborn mice. Virus Res 1993, 27:71–78
10. Feuer R, Pagarigan RR, Harkins S, Liu F, Hunziker IP, Whitton JL:
Coxsackievirus targets proliferating neuronal progenitor cells in the
neonatal CNS. J Neurosci 2005, 25:2434–2444
11. Tabor-Godwin JM, Ruller CM, Bagalso N, An N, Pagarigan RR, Har-
kins S, Gilbert PE, Kiosses WB, Gude NA, Cornell CT, Doran KS,
Sussman MA, Whitton JL, Feuer R: A novel population of myeloid cells
responding to coxsackievirus infection assists in the dissemination of
virus within the neonatal CNS. J Neurosci 2010, 30:8676–8691
12. Tsueng G, Tabor-Godwin JM, Gopal A, Ruller CM, Deline S, An N,
Frausto RF, Milner R, Crocker SJ, Whitton JL, Feuer R: Coxsackievirus
preferentially replicates and induces cytopathic effects in undifferen-
tiated neural progenitor cells. J Virol 2011, 85:5718–5732
13. Rhoades RE, Tabor-Godwin JM, Tsueng G, Feuer R: Enterovirus
infections of the central nervous system. Virology 2011, 411:288–305
14. Feuer R, Mena I, Pagarigan RR, Harkins S, Hassett DE, Whitton JL:
Coxsackievirus B3 and the neonatal CNS: the roles of stem cells,
developing neurons, and apoptosis in infection, viral dissemination,
and disease. Am J Pathol 2003, 163:1379–1393
15. Alvarez-Buylla A, Garcia-Verdugo JM, Tramontin AD: A unified hy-
pothesis on the lineage of neural stem cells. Nat Rev Neurosci 2001,
2:287–293
16. Temple S: The development of neural stem cells. Nature 2001, 414:
112–117
17. Gage FH: Mammalian neural stem cells. Science 2000, 287:1433–
1438
18. Buenz EJ, Rodriguez M, Howe CL: Disrupted spatial memory is a
consequence of picornavirus infection. Neurobiol Dis 2006, 24:266–
273
19. Kandolf R, Sauter M, Aepinus C, Schnorr JJ, Selinka HC, Klingel K:
Mechanisms and consequences of enterovirus persistence in car-
diac myocytes and cells of the immune system. Virus Res 1999,
62:149–158
20. Feuer R, Ruller CM, An N, Tabor-Godwin JM, Rhoades RE, Maciejew-
ski S, Pagarigan RR, Cornell CT, Crocker SJ, Kiosses WB, Pham-
Mitchell N, Campbell IL, Whitton JL: Viral persistence and chronic
immunopathology in the adult central nervous system following Cox-
sackievirus infection during the neonatal period. J Virol 2009, 83:
9356–9369
21. Kim KS, Tracy S, Tapprich W, Bailey J, Lee CK, Kim K, Barry WH,
Chapman NM: 5=-Terminal deletions occur in coxsackievirus B3 dur-
ing replication in murine hearts and cardiac myocyte cultures andcorrelate with encapsidation of negative-strand viral RNA. J Virol
2005, 79:7024–7041
22. Kim KS, Chapman NM, Tracy S: Replication of coxsackievirus B3 in
primary cell cultures generates novel viral genome deletions. J Virol
2008, 82:2033–2037
23. Chapman NM, Kim KS, Drescher KM, Oka K, Tracy S: 5= Terminal
deletions in the genome of a coxsackievirus B2 strain occurred
naturally in human heart. Virology 2008, 375:480–491
24. Hsu KH, Lonberg-Holm K, Alstein B, Crowell RL: A monoclonal anti-
body specific for the cellular receptor for the group B coxsackievi-
ruses. J Virol 1988, 62:1647–1652
25. Bergelson JM, Mohanty JG, Crowell RL, St John NF, Lublin DM,
Finberg RW: Coxsackievirus B3 adapted to growth in RD cells binds
to decay-accelerating factor (CD55). J Virol 1995, 69:1903–1906
26. Bergelson JM: Intercellular junctional proteins as receptors and bar-
riers to virus infection and spread. Cell Host Microbe 2009, 5:517–521
27. Xu R, Crowell RL: Expression and distribution of the receptors for
coxsackievirus B3 during fetal development of the Balb/c mouse and
of their brain cells in culture. Virus Res 1996, 46:157–170
28. Feuer R, Mena I, Pagarigan R, Slifka MK, Whitton JL: Cell cycle status
affects coxsackievirus replication, persistence, and reactivation in
vitro. J Virol 2002, 76:4430–4440
29. Saitoh A, Sawyer MH, Leake JA: Acute disseminated encephalomy-
elitis associated with enteroviral infection. Pediatr Infect Dis J: 2004,
23:1174–1175
30. Rantakallio P, Jones P, Moring J, Von WL: Association between
central nervous system infections during childhood and adult onset
schizophrenia and other psychoses: a 28-year follow-up. Int J Epide-
miol 1997, 26:837–843
31. Woodall CJ, Riding MH, Graham DI, Clements GB: Sequences spe-
cific for enterovirus detected in spinal cord from patients with motor
neurone disease. BMJ 1994, 308:1541–1543
32. Woodall CJ, Graham DI: Evidence for neuronal localisation of entero-
viral sequences in motor neurone disease/amyotrophic lateral scle-
rosis by in situ hybridization. Eur J Histochem 2004, 48:129–134
33. Berger JR, Fee DB, Nelson P, Nuovo G: Coxsackie B meningoen-
cephalitis in a patient with acquired immunodeficiency syndrome and
a multiple sclerosis-like illness. J Neurovirol 2009, 15:282–287
34. Verboon-Maciolek MA, Groenendaal F, Cowan F, Govaert P, van
Loon AM, de Vries LS: White matter damage in neonatal enterovirus
meningoencephalitis. Neurology 2006, 66:1267–1269
35. Buenz EJ, Sauer BM, Lafrance-Corey RG, Deb C, Denic A, German
CL, Howe CL: Apoptosis of hippocampal pyramidal neurons is virus
independent in a mouse model of acute neurovirulent picornavirus
infection. Am J Pathol 2009, 175:668–684
36. Doetsch F: A niche for adult neural stem cells. Curr Opin Genet Dev
2003, 13:543–550
37. Crotty S, Andino R: Implications of high RNA virus mutation rates:
lethal mutagenesis and the antiviral drug ribavirin. Microbes Infect
2002, 4:1301–1307
38. Kishimoto C, Crumpacker CS, Abelmann WH: Ribavirin treatment of
murine coxsackievirus B3 myocarditis with analyses of lymphocyte
subsets. J Am Coll Cardiol 1988, 12:1334–1341
39. Pencea V, Bingaman KD, Freedman LJ, Luskin MB: Neurogenesis in
the subventricular zone and rostral migratory stream of the neonatal
and adult primate forebrain. Exp Neurol 2001, 172:1–16
40. Doetsch F, Caille I, Lim DA, Garcia-Verdugo JM, varez-Buylla A:
Subventricular zone astrocytes are neural stem cells in the adult
mammalian brain. Cell 1999, 97:703–716
41. Alvarez-Buylla A, Garcia-Verdugo JM: Neurogenesis in adult subven-
tricular zone. J Neurosci 2002, 22:629–634
42. Feuer R, Whitton JL: Preferential coxsackievirus replication in prolif-
erating/activated cells: implications for virus tropism, persistence,
and pathogenesis. Curr Top Microbiol Immunol 2008, 323:149–173
43. Mignone JL, Kukekov V, Chiang AS, Steindler D, Enikolopov G:
Neural stem and progenitor cells in nestin-GFP transgenic mice.
J Comp Neurol 2004, 469:311–324
44. Kim Y, Comte I, Szabo G, Hockberger P, Szele FG: Adult mouse
subventricular zone stem and progenitor cells are sessile and epi-
dermal growth factor receptor negatively regulates neuroblast migra-
tion. PLoS One 2009, 4:e8122
45. Barraud P, Thompson L, Kirik D, Bjorklund A, Parmar M: Isolation and
characterization of neural precursor cells from the Sox1-GFP reporter
mouse. Eur J Neurosci 2005, 22:1555–1569
1120 Ruller et al
AJP March 2012, Vol. 180, No. 346. Connor E, Morrison S, Lane J, Oleske J, Sonke RL, Connor J: Safety,
tolerance, and pharmacokinetics of systemic ribavirin in children with
human immunodeficiency virus infection. Antimicrob Agents Che-
mother 1993, 37:532–539
47. Outbreaks of aseptic meningitis associated with echoviruses 9 and
30 and preliminary surveillance reports on enterovirus activity–United
States, 2003. MMWR Morb Mortal Wkly Rep 2003, 52:761–764
48. Luo MH, Schwartz PH, Fortunato EA: Neonatal neural progenitor cells
and their neuronal and glial cell derivatives are fully permissive for
human cytomegalovirus infection. J Virol 2008, 82:9994–10007
49. Cheeran MC, Hu S, Ni HT, Sheng W, Palmquist JM, Peterson PK,
Lokensgard JR: Neural precursor cell susceptibility to human cyto-
megalovirus diverges along glial or neuronal differentiation pathways.
J Neurosci Res 2005, 82:839–850
50. Das S, Basu A: Japanese encephalitis virus infects neural progenitor
cells and decreases their proliferation. J Neurochem 2008, 106:
1624–1636
51. Das S, Chakraborty S, Basu A: Critical role of lipid rafts in virus entry
and activation of phosphoinositide 3= kinase/Akt signaling during
early stages of Japanese encephalitis virus infection in neural stem/
progenitor cells. J Neurochem 2010, 115(2):537–54952. Luo MH, Hannemann H, Kulkarni AS, Schwartz PH, O’Dowd JM,
Fortunato EA: Human cytomegalovirus infection causes premature
and abnormal differentiation of human neural progenitor cells. J Virol
2010, 84:3528–3541
53. Odeberg J, Wolmer N, Falci S, Westgren M, Sundtrom E, Seiger A,
Soderberg-Naucler C: Late human cytomegalovirus (HCMV) proteins
inhibit differentiation of human neural precursor cells into astrocytes.
J Neurosci Res 2007, 85:583–593
54. Odeberg J, Wolmer N, Falci S, Westgren M, Seiger A, Soderberg-
Naucler C: Human cytomegalovirus inhibits neuronal differentiation
and induces apoptosis in human neural precursor cells. J Virol 2006,
80:8929–8939
55. Okamoto S, Kang YJ, Brechtel CW, Siviglia E, Russo R, Clemente A,
Harrop A, McKercher S, Kaul M, Lipton SA: HIV/gp120 decreases
adult neural progenitor cell proliferation via checkpoint kinase-medi-
ated cell-cycle withdrawal and G1 arrest. Cell Stem Cell 2007, 1:230–
236
56. Shahar E, Andraus J, Savitzki D, Pilar G, Zelnik N: Outcome of severe
encephalomyelitis in children: effect of high-dose methylprednisolone
and immunoglobulins. J Child Neurol 2002, 17:810–814
